MYP_107159
Basic Information
Unnamed
Anticancer
Immunology Immunomodulation Immunogenic
Standard
9 amino acids
C44H71N9O13S2
Standard
Sequence
CYMEAVALV
Physicochemical Analysis
998.22 Da
4.05
-1.25
-1.47
-0.1387
1.71
0.22
0.55
57.71
130.00
0.1111
1490.00
1490.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
353.65
-0.83
13.0
14.0
30.0
68.0
1.0
8.0
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0131015 VERIFIED: YES
Provenance & Taxonomy
Homo sapiens [Animal]
Neoantigen
9606
Structure & Mods
linear peptide [Linear]
mixed L/D amino-acid peptide [Mixed]
Bio-Activity Profile
Anticancer Immunogenic
Ovarian Cancer; HLA-C*14:03
ELISPOT
RECORD: Rec_0280584 VERIFIED: NO
Provenance & Taxonomy
Homo sapiens [Animal]
Neoantigen
9606
Structure & Mods
linear peptide [Linear]
mixed L/D amino-acid peptide [Mixed]
Bio-Activity Profile
Anticancer
Ovarian Cancer; HLA-C*14:03
0.0729 μM
Predicted HLA-I binding